awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26740359-CE2A2994-8205-4615-9B5C-C5341EB70B7F
Q26740359-CE2A2994-8205-4615-9B5C-C5341EB70B7F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26740359-CE2A2994-8205-4615-9B5C-C5341EB70B7F
Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future?
P2860
Q26740359-CE2A2994-8205-4615-9B5C-C5341EB70B7F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26740359-CE2A2994-8205-4615-9B5C-C5341EB70B7F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4d0dff757c5d0b8f5e13ca896b2f03e451ceeba
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.